Skip to main content
Premium Trial:

Request an Annual Quote

PerkinElmer Sells $150M in Senior Notes in Private Placement

NEW YORK (GenomeWeb News) – PerkinElmer disclosed in a filing with the US Securities and Exchange Commission yesterday that it has privately placed $150 million of 6 percent Series 2008-A Senior Notes due May 30, 2015, with a number of investors.
Under the terms of the agreement, PerkinElmer said that it may its own discretion issue additional senior notes in the amount of up to $400 million. The firm said that it may use the proceeds from the offering to finance mergers, acquisitions, capital expenditures, stock repurchases, dividends, debt refinancing, and for other general corporate purposes.
According to the filing, note holders include Northwestern Mutual Life Insurance Company, New York Life Insurance Company, Aviva Life and Annuity Company, Hartford Life and Accident Insurance Company, Allianz Life Insurance Company of North America, and several other investors.

The Scan

Self-Reported Hearing Loss in Older Adults Begins Very Early in Life, Study Says

A JAMA Otolaryngology — Head & Neck Surgery study says polygenic risk scores associated with hearing loss in older adults is also associated with hearing decline in younger groups.

Genome-Wide Analysis Sheds Light on Genetics of ADHD

A genome-wide association study meta-analysis of attention-deficit hyperactivity disorder appearing in Nature Genetics links 76 genes to risk of having the disorder.

MicroRNA Cotargeting Linked to Lupus

A mouse-based study appearing in BMC Biology implicates two microRNAs with overlapping target sites in lupus.

Enzyme Involved in Lipid Metabolism Linked to Mutational Signatures

In Nature Genetics, a Wellcome Sanger Institute-led team found that APOBEC1 may contribute to the development of the SBS2 and SBS13 mutational signatures in the small intestine.